Fibrocell Science, Inc.
DelistedCIK 357097fmd_1CWEZE79JFV9Z594NMPFTNGM6RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2004 to Sep 30, 2019, 40 periods
| Line item | FY2007 | FY2008 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | – | – | 0 | 8 | 8 | 2 | 1 | 1 | 0 | – |
| Net interest income | – | – | – | (1) | 0 | 0 | 0 | (0) | 0 | 0 |
| Gross profit | – | – | (0) | (8) | (7) | (2) | (0) | (0) | 0 | – |
| Research and development | – | – | 7 | 10 | 4 | 8 | 10 | 8 | 7 | 6 |
| Selling, general and administrative | – | – | 13 | 12 | 9 | 10 | 11 | 10 | 7 | 6 |
| Total operating expenses | – | – | – | – | – | – | – | – | 19 | 12 |
| Operating income | – | – | (20) | (29) | (31) | (30) | (37) | (26) | (19) | (12) |
| Interest expense | – | – | 1 | 1 | (0) | – | 0 | 0 | 1 | 1 |
| Other non-operating income (expense) | – | – | – | – | – | – | 0 | (0) | – | – |
| Income before taxes | – | – | (24) | (13) | (32) | (26) | (34) | (15) | (16) | (10) |
| Income tax expense | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (24) | (13) | (32) | (26) | (34) | (15) | (16) | (10) |
| Net income | (36) | (33) | (24) | (13) | (32) | (26) | (34) | (15) | (16) | (10) |
| Net income to common shareholders | – | – | (24) | (13) | (32) | (26) | (34) | (15) | (21) | (11) |